These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Fertile women and valproate. Reactions to information about the possible teratogenic effect]. Philbert A; Pedersen B Ugeskr Laeger; 1984 Jul; 146(27):2006-7. PubMed ID: 6440328 [No Abstract] [Full Text] [Related]
4. Valproate and babies. Whitehall J; Smith J Aust N Z J Psychiatry; 2008 Sep; 42(9):837. PubMed ID: 18696289 [No Abstract] [Full Text] [Related]
5. Rare but real--the effects of sodium valproate in pregnancy. Reardon W Ir Med J; 2011 Jun; 104(6):165-6. PubMed ID: 22111389 [No Abstract] [Full Text] [Related]
6. A case of fetal anticonvulsant syndrome with severe bilateral upper limb defect. Guven MA; Batukan C; Ceylaner S; Ceylaner G; Uzel M J Matern Fetal Neonatal Med; 2006 Feb; 19(2):115-7. PubMed ID: 16676441 [TBL] [Abstract][Full Text] [Related]
7. Pregnancy treatment guidelines: throwing the baby out with the bath water. Somerville ER; Cook MJ; O'Brien TJ Epilepsia; 2009 Sep; 50(9):2172. PubMed ID: 19706065 [No Abstract] [Full Text] [Related]
8. Valpromide/carbamazepine and risk of teratogenicity. Pacifici GM; Tomson T; Bertilsson L; Rane A Lancet; 1985 Feb; 1(8425):397-8. PubMed ID: 2857448 [No Abstract] [Full Text] [Related]
9. Valproate: a new cause of birth defects--report from Italy and follow-up from France. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1983 Aug; 32(33):438-9. PubMed ID: 6410178 [No Abstract] [Full Text] [Related]
10. Sodium valproate, carbamazepine and spina bifida. Oakeshott P Br J Gen Pract; 1991 Nov; 41(352):478-9. PubMed ID: 1807316 [No Abstract] [Full Text] [Related]
11. Septo-optic dysplasia as a manifestation of valproic acid embryopathy. McMahon CL; Braddock SR Teratology; 2001 Aug; 64(2):83-6. PubMed ID: 11460259 [TBL] [Abstract][Full Text] [Related]
12. [Spina bifida caused by valproic acid?]. ten Kate LP; Swagemakers ML; Weemhoff RA; van Eck JH Ned Tijdschr Geneeskd; 1983 Mar; 127(11):469-70. PubMed ID: 6405287 [No Abstract] [Full Text] [Related]
13. Anomalous right pulmonary artery origins in association with the fetal valproate syndrome. Mo CN; Ladusans EJ J Med Genet; 1999 Jan; 36(1):83-4. PubMed ID: 9950375 [TBL] [Abstract][Full Text] [Related]
14. [Severe bone malformations in fetal valproic acid disease]. Lorenzo Sanz G; Serna Saugar C; Quintana Castilla A; Lozano Giménez C; Aparicio Meix JM An Esp Pediatr; 1993 Jul; 39(1):19-21. PubMed ID: 8363144 [TBL] [Abstract][Full Text] [Related]
15. Case-control studies using only malformed infants: are we interpreting the results correctly? Prieto L; Martínez-Frías ML Teratology; 1999 Jul; 60(1):1-2. PubMed ID: 10413329 [No Abstract] [Full Text] [Related]
18. The fetal valproate syndrome. Wellesley D Am J Med Genet; 1988 Oct; 31(2):475, 477-8. PubMed ID: 3148280 [No Abstract] [Full Text] [Related]
19. Congenital nasolacrimal duct obstruction requiring external dacryocystorhinostomies in a child with foetal valproate syndrome. Hornby SJ; Welham RA Eye (Lond); 2003 May; 17(4):546-7. PubMed ID: 12802369 [No Abstract] [Full Text] [Related]
20. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. Kozma C Am J Med Genet; 2001 Jan; 98(2):168-75. PubMed ID: 11223853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]